-
CUX2 Neuron Loss and DNA Damage in Neuroinflammation
2026-08-22
The reference study identifies accumulated DNA damage and insufficient double-strand-break repair as a mechanistic basis for the selective loss of CUX2-positive layer 2/3 excitatory neurons in multiple sclerosis and mouse neuroinflammation models. Its human-to-animal-to-cellular design links interferon-γ-driven oxidative stress with neuronal vulnerability and provides a framework for studying cell-type-specific degeneration.
-
NHS-Biotin: Reliable Protein Labeling in Cell Assays
2026-08-21
NHS-Biotin (SKU A8002) provides a practical route to stable amine-reactive labeling for antibody, protein, surface, and intracellular workflows that support cell-based assay interpretation. This scenario-driven guide explains chemistry, compatibility, handling, data normalization, and vendor-selection considerations for reproducible protein detection and purification.
-
Annexin V-APC/7-AAD Apoptosis Kit Workflow
2026-08-20
Build a rapid dual-parameter workflow that separates viable, early apoptotic, late apoptotic, and membrane-compromised cells. The Annexin V-APC/7-AAD Apoptosis Kit is especially useful for linking immune-checkpoint perturbation with tumor-cell and T-cell fate in cancer models.
-
Rab26 Deficiency Disrupts SERT Trafficking in Mice
2026-08-20
The reference study links Rab26 loss to depression- and anxiety-like behaviors, cognitive impairment, altered synaptic physiology, and defective serotonin transporter (SERT) trafficking. Its central innovation is the identification of a Rab26–SERT regulatory pathway connecting membrane transport, autophagic degradation, serotonin uptake, and behavioral phenotypes.
-
Sulfo-NHS-SS-Biotin for Surface Protein Trafficking
2026-08-19
Sulfo-NHS-SS-Biotin combines cell-impermeant surface labeling with a cleavable disulfide linker, making it useful for tracking membrane delivery and recovering labeled proteins. This practical guide connects reversible biotinylation to invadopodium studies of MT1-MMP, EGFR, Munc18c, and syntaxin4 while emphasizing workflow control and troubleshooting.
-
TH287 Sensitizes CRPC Cells to Radiation
2026-08-19
A 2026 study found that TH287 enhanced ionizing-radiation responses in PC-3 and DU-145 castration-resistant prostate cancer cells, with the strongest effect when radiation followed inhibitor exposure by 12 hours. The work adds a practical timing variable to MTH1-based radiosensitization and links the combination to increased apoptosis and cell-cycle disruption.
-
LY2228820: p38 MAP kinase inhibitor workflows
2026-08-18
LY2228820 enables controlled inhibition of p38α/β signaling across biochemical, inflammatory, and cancer research workflows. Its nanomolar biochemical potency, formulation flexibility, and compatibility with phospho-MK2, cytokine, and apoptosis readouts support mechanism-focused experiments rather than single-endpoint screening.
-
Gut-Brain Cholinergic Signaling in Seizure Control
2026-08-18
Jia et al. identify a gut-vagus-brain cholinergic circuit through which Bacteroides fragilis suppresses seizures in mouse models and improves outcomes in a pediatric refractory epilepsy trial. The study connects microbial composition, colonic ChAT-positive cells, vagal transmission, and acetylcholine receptor activation, providing a mechanistic framework for microbiota-based antiseizure research.
-
Anlotinib Hydrochloride in Angiogenesis Assays
2026-08-17
Anlotinib hydrochloride enables a multi-pathway approach to angiogenesis research by targeting VEGFR2, PDGFRβ, FGFR1, and downstream ERK signaling. This practical guide connects endothelial migration, tube formation, mechanistic readouts, and vascular sprouting models with troubleshooting strategies for reproducible cancer research.
-
Tanshinone IIA Pathways in Psoriasis: Study Analysis
2026-08-17
This study combines network pharmacology, cellular assays, molecular docking, and an imiquimod-induced mouse model to examine how tanshinone IIA may suppress psoriasis-associated inflammation. Its central contribution is linking the IL-17/IL-23 axis with PTGS2/NF-κB/AP-1 signaling and showing stronger pathway inhibition when tanshinone IIA is combined with methotrexate.
-
CPSIT_0844 Drives IL-6/IL-8 via TLR2/4
2026-08-16
This 2026 Immunobiology study identifies the Chlamydia psittaci inclusion membrane protein CPSIT_0844 as a proinflammatory stimulus in human THP-1 monocytes. Its experiments connect CPSIT_0844 to TLR2/TLR4–MyD88 signaling and downstream JNK, p38, and NF-κB activation, providing a mechanistic framework for inflammation research on psittacosis.
-
Taltirelin Acetate: OSA and Neuroprotection Workflows
2026-08-15
Taltirelin acetate supports distinct preclinical workflows, from sleep-state analysis of hypoglossal motor output to neuroprotection assays and formulation testing. This guide translates the reference study into practical dosing, controls, troubleshooting, and cross-application decision points.
-
O6-Benzylguanine: MGMT Inhibition Workflow
2026-08-14
O6-Benzylguanine enables controlled MGMT blockade for studying DNA repair inhibition and sensitization to alkylating agents. This workflow connects mechanistic enzyme inhibition with recurrent glioma models, combination-dose design, and practical troubleshooting for cancer chemotherapy research.
-
FAST Nanoparticles for Food-Grade Nutraceutical Delivery
2026-08-14
Cai and colleagues evaluated Facilitated Self-Assembling Technology (FAST) as a surfactant-free, food-grade route for producing stable nanoparticles from poorly soluble nutraceuticals. The study links spontaneous assembly with improved colloidal behavior, simulated gastric stability, biocompatibility, and fluorescent visualization of nanoparticle–cell interactions, while also identifying limitations that must be addressed before broad translation.
-
NHS-Biotin in Reliable Labeling Workflows
2026-08-13
NHS-Biotin (SKU A8002) provides a practical, amine-reactive route for labeling antibodies, proteins, and intracellular targets used in viability, proliferation, and cytotoxicity workflows. This scenario-based guide explains compatibility, protocol controls, data interpretation, and vendor-selection criteria for more reproducible streptavidin-based detection and purification.